Abstract:Purpose: The generation of genetically corrected RPE cells from patient‐derived human induced pluripotent stem cells (hiPSCs) may provide a source for autologous therapeutically‐relevant therapy for this rare retinal dystrophy as well to create the human cellular disease models. Recently we generated a faithful RPE model from patient bearing mutation in MERTK gene and genetically corrected these cells using CRISPR/Cas9 system. For further application in humans is necessary in vivo validation for survival. Methods: The RPE cells from the genetically corrected patient‐derived hiPSC were characterized using immunocytological methods for the differentiation and polarization markers, electronic microscopy, RT‐PCR, TEER measurement, ELISA test, Western Blot and phagocytic assay. The implantations of RPE‐scaffolds were carried out into the minipig eyes. Due to the xenogeneic transplantation of human cells into minipig eyes, tacrolimus immunosuppression therapy was used. At the 2‐week follow‐up from transplantation, non‐invasive OCT and fundus camera examinations of the implanted RPE‐scaffolds were performed. Consequently, euthanasia, histological and immunohistochemical investigations of the implanted retina were performed. Results: All generated RPE cells exhibit typical features of RPE cells. We demonstrated the reestablishment of the expression of full‐length MERTK protein as well as the reversion of lost phagocyte function of hiPSC‐RPE in vitro, which represents the first example of its kind in this field. Histological and immunohistochemical investigation of the RPE implants and adjacent retina showed structurally healthy RPE‐scaffold implant and neuroretinal cells above the implant. Conclusions: The generated hiPSC‐derived RPE in clinical grade conditions display the typical characteristics of mature RPE cells re‐establishing the function of phagocytosis in genetically corrected patient‐derived RPE cells in vitro. Functional in vivo studies in minipigs confirmed the RPE survival as well as survival of adjacent photoreceptors and thus can be employed as a potential treatment for patients.

De novo pigmentation of amelanotic retinal pigment epithelium – An ex vivo model

Stem Cell Derived Retinal Pigment Epithelium: The Role of Pigmentation as Maturation Marker and Gene Expression Profile Comparison with Human Endogenous Retinal Pigment Epithelium.

Differentiation of Adult Human Retinal Pigment Epithelial Cells into Dopaminergic-Like Cells in Vitro and in the Recipient Monkey Brain

Polydopamine Nanoparticles as Mimicking RPE Melanin for the Protection of Retinal Cells Against Blue Light‐Induced Phototoxicity

Glial Cell Responses and Gene Expression Dynamics in Retinas of Treated and Untreated RPE65 Mutant Dogs

Polydopamine Nanoparticles as Mimicking RPE Melanin for the Protection of Retinal Cells Against Blue Light-Induced Phototoxicity

Retinal Pigment Epithelium Remodeling in Mouse Models of Retinitis Pigmentosa

Human iPSC ‐derived RPE cells implantation into minipig eye: Two weeks follow‐up study

In vitro and in vivo evaluation of genetically corrected RPE cells for autologous cell therapy of hereditary retinal dystrophies

Transplantation of retinal pigment epithelium and photoreceptors generated concomitantly via small molecule-mediated differentiation rescues visual function in rodent models of retinal degeneration

Generation of Retinal Pigment Epithelial Cells from Small Molecules and OCT4 Reprogrammed Human Induced Pluripotent Stem Cells.

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Antioxidant Properties of Melanin in Retinal Pigment Epithelial Cells

Selective nanosecond laser removal of retinal pigment epithelium for cell therapy

Development Of Retinal Pigment Epithelium From Human Parthenogenetic Embryonic Stem Cells And Microrna Signature

Intrinsically Photosensitive Retinal Ganglion Cells Detect Light with a Vitamin A-based Photopigment, Melanopsin

Aberrant Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem Cells of a Retinitis Pigmentosa Patient with the PRPF6 Mutation

Global Transcriptional and Epigenetic Reconfiguration During Chemical Reprogramming of Human Retinal Pigment Epithelial Cells into Photoreceptor-like Cells

In vivo Optical Coherence Tomography of Light-Driven Melanosome Translocation in Retinal Pigment Epithelium

Human RPE Melanosomes Protect from Photosensitized and Iron-Mediated Oxidation but Become Pro-oxidant in the Presence of Iron upon Photodegradation

Protective effects of human iPS-derived retinal pigmented epithelial cells on retinal degenerative disease